| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 72 |
| 1 | METHOTREXATE SODIUM | 62 |
| 2 | ETANERCEPT | 56 |
| 3 | METHOTREXATE | 56 |
| 4 | PREDNISONE | 41 |
| 5 | INTERFERON BETA-1A | 40 |
| 6 | CYCLOPHOSPHAMIDE | 39 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 39 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 39 |
| 9 | RITUXIMAB | 39 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | WHITE PETROLEUM | 2 | 0.0385 |
| 1 | AESCULUS HIPPOCASTANUM WHOLE | 1 | 0.0133 |
| 2 | AGRIMONIA EUPATORIA | 1 | 0.0132 |
| 3 | CENTAURIUM ERYTHRAEA | 1 | 0.0130 |
| 4 | DIFLORASONE DIACETATE | 2 | 0.0104 |
| 5 | TOBRAMYCIN / DEXAMETHASONE | 1 | 0.0077 |
| 6 | ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE | 1 | 0.0076 |
| 7 | PANTHENOL | 2 | 0.0068 |
| 8 | ALCLOMETASONE DIPROPIONATE | 2 | 0.0064 |
| 9 | HALOBETASOL PROPIONATE AND TAZAROTENE | 1 | 0.0051 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 115 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 98 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 97 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 56 |
| 4 | Vitamin C [EPC] | 49 |
| 5 | Alkylating Drug [EPC] | 47 |
| 6 | Benzodiazepine [EPC] | 44 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 43 |
| 8 | Vitamin B12 [EPC] | 41 |
| 9 | Interferon beta [EPC] | 40 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 1 | Interleukin-1 Receptor Antagonist [EPC] | 24 | 0.0014 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 26 | 0.0013 |
| 3 | Prostacycline [EPC] | 1 | 0.0011 |
| 4 | Aryl Hydrocarbon Receptor Agonist [EPC] | 1 | 0.0005 |
| 5 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 6 | Antiseptic [EPC] | 2 | 0.0005 |
| 7 | Antiparasitic [EPC] | 2 | 0.0004 |
| 8 | Oxazolidinone Antibacterial [EPC] | 13 | 0.0004 |
| 9 | Pediculicide [EPC] | 2 | 0.0004 |